Total Payments
$355,413
2024 Payments
$24,988
Companies
18
Transactions
433
Medicare Patients
23,609
Medicare Billing
$844,272
Payment Breakdown by Category
Other$318,014 (89.5%)
Food & Beverage$14,618 (4.1%)
Travel$14,482 (4.1%)
Consulting$8,249 (2.3%)
Education$50.15 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $284,026 | 154 | 79.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $27,599 | 12 | 7.8% |
| Food and Beverage | $14,618 | 168 | 4.1% |
| Travel and Lodging | $14,482 | 80 | 4.1% |
| Consulting Fee | $8,249 | 6 | 2.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $5,700 | 7 | 1.6% |
| Honoraria | $690.00 | 1 | 0.2% |
| Education | $50.15 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $132,500 | 144 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $75,132 | 88 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $60,522 | 82 | $0 (2024) |
| Dexcom, Inc. | $29,275 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $22,956 | 30 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $21,691 | 21 | $0 (2023) |
| Abbott Laboratories | $8,716 | 19 | $0 (2022) |
| Ascensia Diabetes Care Us Inc. | $3,540 | 6 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $690.00 | 1 | $0 (2021) |
| Eisai Inc. | $124.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,988 | 28 | Novo Nordisk Inc ($12,036) |
| 2023 | $43,623 | 45 | Dexcom, Inc. ($16,224) |
| 2022 | $48,122 | 52 | Novo Nordisk Inc ($29,180) |
| 2021 | $29,252 | 41 | Novo Nordisk Inc ($21,502) |
| 2020 | $19,017 | 24 | Novo Nordisk Inc ($8,582) |
| 2019 | $35,412 | 38 | Janssen Pharmaceuticals, Inc ($19,710) |
| 2018 | $72,903 | 107 | SANOFI-AVENTIS U.S. LLC ($30,282) |
| 2017 | $82,096 | 98 | Janssen Pharmaceuticals, Inc ($33,582) |
All Payment Transactions
433 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,093.75 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $188.94 | General |
| 11/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.25 | General |
| 11/05/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,298.00 | General |
| Category: Endocrinology | ||||||
| 10/11/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Travel and Lodging | Cash or cash equivalent | $96.48 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $383.00 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,281.25 | General |
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $118.39 | General |
| 09/12/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $99.16 | General |
| 07/22/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/18/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,437.50 | General |
| 04/18/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.40 | General |
| 04/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,754.50 | General |
| Category: Diabetes | ||||||
| 03/21/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/18/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,320.00 | General |
| Category: Endocrinology | ||||||
| 02/26/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/30/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Travel and Lodging | In-kind items and services | $64.00 | General |
| Category: Diabetes | ||||||
| 01/20/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $123.06 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Travel and Lodging | In-kind items and services | $467.10 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 5,229 | 8,798 | $472,800 | $200,325 |
| 2022 | 24 | 5,834 | 9,618 | $507,039 | $211,680 |
| 2021 | 25 | 6,297 | 10,985 | $541,969 | $234,753 |
| 2020 | 24 | 6,249 | 10,212 | $501,104 | $197,514 |
Total Patients
23,609
Total Services
39,613
Medicare Billing
$844,272
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 426 | 866 | $173,200 | $81,044 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 455 | $68,250 | $28,438 | 41.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 648 | 1,162 | $39,508 | $19,073 | 48.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 541 | 1,080 | $34,560 | $10,248 | 29.7% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 341 | 587 | $19,958 | $9,713 | 48.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 454 | 930 | $27,900 | $9,593 | 34.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 629 | 1,099 | $10,990 | $9,224 | 83.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 489 | 806 | $27,404 | $7,102 | 25.9% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 87 | 155 | $15,500 | $4,079 | 26.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 203 | 264 | $7,920 | $3,452 | 43.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 94 | 109 | $8,175 | $3,162 | 38.7% |
| 83721 | Ldl cholesterol level | Office | 2023 | 204 | 264 | $5,280 | $2,696 | 51.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,325 | $2,561 | 40.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 249 | 335 | $5,360 | $1,883 | 35.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 248 | 334 | $5,010 | $1,685 | 33.6% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 150 | 182 | $5,460 | $1,509 | 27.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 26 | 37 | $2,405 | $1,497 | 62.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,920 | $1,000 | 25.5% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 17 | 21 | $1,575 | $930.93 | 59.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 19 | 30 | $1,950 | $758.70 | 38.9% |
| 84432 | Thyroglobulin (thyroid related hormone) level | Office | 2023 | 29 | 43 | $2,150 | $676.82 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 428 | 881 | $176,200 | $83,924 | 47.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 372 | 532 | $79,800 | $33,719 | 42.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 677 | 1,185 | $40,290 | $19,634 | 48.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 558 | 1,152 | $36,864 | $11,029 | 29.9% |
About Dr. Robert Dobrzynski, M.D
Dr. Robert Dobrzynski, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598863599.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Dobrzynski, M.D has received a total of $355,413 in payments from pharmaceutical and medical device companies, with $24,988 received in 2024. These payments were reported across 433 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($284,026).
As a Medicare-enrolled provider, Dobrzynski has provided services to 23,609 Medicare beneficiaries, totaling 39,613 services with total Medicare billing of $844,272. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Providence, RI
- Active Since 09/21/2006
- Last Updated 12/17/2012
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1598863599
Products in Payments
- INVOKANA (Drug) $75,143
- SOLIQUA (Drug) $36,302
- Ozempic (Drug) $32,937
- DEXCOM G7 GSS (161) (Medical Supply) $25,432
- TOUJEO (Drug) $24,187
- FARXIGA (Drug) $22,956
- RYBELSUS (Drug) $22,917
- Kerendia (Drug) $21,691
- Tresiba (Drug) $17,448
- Victoza (Drug) $14,448
- Rybelsus (Drug) $13,424
- FreeStyle Libre Pro (Device) $3,908
- Dexcom G6 Transmitter (Medical Supply) $3,843
- EVERSENSE E3 SENSOR KIT - RETAIL (Device) $3,540
- FreeStyle Libre (Device) $3,525
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $1,258
- GVOKE PFS (Drug) $690.00
- Lenvima (Drug) $124.80
- FIASP (Drug) $102.41
- TEPEZZA (Biological) $78.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Providence
Robert Smith, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $106,699
Endocrinology, Diabetes & Metabolism $106,699
Dr. Joseph Tucci, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $50,880
Endocrinology, Diabetes & Metabolism $50,880
Kenneth Chen, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,625
Endocrinology, Diabetes & Metabolism $11,625
Roberto Ortiz, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $493.63
Endocrinology, Diabetes & Metabolism $493.63
Charles Kahn, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $249.96
Endocrinology, Diabetes & Metabolism $249.96
Ivana Lukacova-Zib, M.d, M.D
Endocrinology, Diabetes & Metabolism
Endocrinology, Diabetes & Metabolism